SLN365
/ Silence Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 05, 2026
Anticipated 2026 Milestones
(Businesswire)
- "Additional preclinical data for SLN365 (GPR146) in second quarter of 2026; Additional preclinical data for SLN098 (INHBE) in second quarter of 2026."
Preclinical • Homozygous Familial Hypercholesterolemia • Obesity
1 to 1
Of
1
Go to page
1